TACI/TNFRSF13B/CVID Antibody (165604) [Janelia Fluor™ 585], Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NB472809-Each-of-1 | In Stock | ₹ 66,693.93 |
NB472809 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 66,693.93
GST (18%): ₹ 12,004.907
Total Price: ₹ 78,698.837
Antigen
TACI/TNFRSF13B/CVID
Classification
Monoclonal
Conjugate
Janelia Fluor 585
Gene Alias
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Immunogen
Mouse myeloma cell line NS0-derived recombinant human TACI/TNFRSF13B, Ser2-Thr166, Accession # O14836
Quantity
0.5 mL
Research Discipline
Apoptosis, B Cell Development and Differentiation Markers, Signal Transduction
Gene ID (Entrez)
23495
Content And Storage
Store at 4°C in the dark.
Isotype
IgG1
Applications
Flow Cytometry, Blockade of Receptor-ligand Interaction, CyTOF
Clone
165604
Formulation
50mM Sodium Borate
Host Species
Mouse
Purification Method
Protein A or G purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Form
Purified
Related Products
Description
- TACI/TNFRSF13B/CVID Monoclonal antibody specifically detects TACI/TNFRSF13B/CVID in Human samples
- It is validated for Flow Cytometry,Blockade of Receptor-ligand Interaction,CyTOF